Chemical Component Summary

NamePYRAZINE-2-CARBOXAMIDE
Identifierspyrazine-2-carboxamide
FormulaC5 H5 N3 O
Molecular Weight123.11
TypeNON-POLYMER
Isomeric SMILESNC(=O)c1cnccn1
InChIInChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)
InChIKeyIPEHBUMCGVEMRF-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count14
Chiral Atom Count0
Bond Count14
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB00339 
NamePyrazinamide
Groups
  • approved
  • investigational
DescriptionA pyrazine that is used therapeutically as an antitubercular agent.
Synonyms
  • Pyrazine carboxamide
  • Pyrazinecarboxamide
  • Pyrazinamida
  • Pyrazinamid
  • pyrazine-2-carboxamide
Brand Names
  • Pdp-pyrazinamide
  • Rifater
  • Tebrazid
  • Pyrazinamide
IndicationFor the initial treatment of active tuberculosis in adults and children when combined with other antituberculous agents.
Categories
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Antiinfectives for Systemic Use
  • Antimycobacterials
  • Antituberculosis Agents
ATC-Code
  • J04AK01
  • J04AM06
  • J04AM05
CAS number98-96-4

Drug Targets

NameTarget SequencePharmacological ActionActions
Fatty acid synthetaseMTIHEHDRVSADRGGDSPHTTHALVDRLMAGEPYAVAFGGQGSAWLETLE...unknowninhibitor
Xanthine dehydrogenase/oxidaseMTADKLVFFVNGRKVVEKNADPETTLLAYLRRKLGLSGTKLGCGEGGCGA...unknownsubstrate
Aldehyde oxidaseMDRASELLFYVNGRKVIEKNVDPETMLLPYLRKKLRLTGTKYGCGGGGCG...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682